Scientists identified a driver of aggressive prostate cancer and a potential way to stop drug-resistant tumors forming.

The American Cancer Society predicts 1 in 8 men will be diagnosed with prostate cancer in their lifetime.

As the standards of care for prostate cancer change, new drugs, combination therapies, and trials enter the therapeutic space ...

"The number of men living with prostate cancer also continues to rise, so it's vital that we see investment in prostate ...

Prostate cancer is 2nd most commonly occurring cancer in men but also one of the least understood. Here are nine things the ...

Men in England diagnosed with incurable advanced prostate cancer are more likely to survive for at least three years than ...

Bruce Arians shared his prostate cancer survival story during the NFL's "Crucial Catch" week, urging men to get a simple PSA ...

Profound Medical (NASDAQ:PROF) and Telix Pharmaceuticals (NASDAQ:TLX) have signed a co-education agreement aimed at increasing physician awareness of how advanced diagnostic imaging can support ...

Men newly diagnosed with prostate cancer face a range of treatment options, from robotic surgery and focal therapy to ...

VIR-5500 and [²¹²Pb]PSV359 received FDA fast track designations for prostate cancer and solitary fibrous tumors, respectively ...

Five-treatment stereotactic body radiation therapy (SBRT) provided excellent long-term cancer control with fewer urinary and ...

Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine ...